Bradley Eilerman is an Endocrinology/Metabolic physician. OpenAlex indexes 25 publications with 283 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7388 Turfway Rd
Florence, KY 410421381
Telephone
859-655-8910Provider last certified this registry record 30 Apr 2024.
Industry payments
71 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year2025128 payments$146,974openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year2025111 payments$85,007openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year202543 payments$14,253openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
48.6%GLP-1 receptor agonist13.1%Mounjaro44%Ozempic40%Trulicity9%Rybelsus5%Wegovy3%Part D<11 patientsBiguanide (metformin)9.1%Metformin Hcl Er81%Metformin Hcl19%Part D≥163 patients+ 11 more classes in this area
Cardiovascular
22.5%Statin9.1%Rosuvastatin Calcium75%Atorvastatin Calcium20%Pravastatin Sodium5%Part D<11 patientsAngiotensin receptor blocker (ARB)4%Valsartan50%Olmesartan Medoxomil27%Valsartan-Hydrochlorothiazide13%Losartan Potassium10%Part D<11 patients+ 12 more classes in this area
Hormonal (systemic)
19.5%l-Thyroxine17.3%Levothyroxine Sodium80%Synthroid19%Tirosint2%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.8%Methimazole100%Part D≥16 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”